Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 617-116-8
CAS number: 80573-04-2
The acute oral toxicity studies show that Balsalazide disodium and hence
balsalazide acid are not toxic when administered to rats as a single
oral dose of 2000 and 5000 mg/kg bw. No mortalities, adverse effects or
clinical signs were observed during the studies. Therefore, the highest
doses tested were considered to be the non-lethal doses and the LD50 in
rats is considered to be greater than 2000 mg/kg bw.
No mortalities, adverse effects or clinical signs were observed during
the acute oral toxicity studies. Therefore, the highest doses tested
were considered to the non-lethal doses and the LD50 is greater than
2000 mg/kg bw and is therefore above the dose required for
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Ce site web utilise des cookies afin de vous garantir la meilleure expérience possible sur nos sites web.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again